ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Homozygous Familial Hypercholesterolemia Treatment Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-14T9506
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Homozygous Familial Hypercholesterolemia Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Homozygous Familial Hypercholesterolemia Treatment Market Research Report 2025

Code: QYRE-Auto-14T9506
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CymaBay Therapeutics Inc
Daewoong Co Ltd
Gemphire Therapeutics Inc
LipimetiX Development Inc
Regeneron Pharmaceuticals Inc
REGENXBIO
The Medicines Company

Homozygous Familial Hypercholesterolemia Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Homozygous Familial Hypercholesterolemia Treatment Market

Homozygous Familial Hypercholesterolemia Treatment Market

The global market for Homozygous Familial Hypercholesterolemia Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Homozygous Familial Hypercholesterolemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Homozygous Familial Hypercholesterolemia Treatment.
The Homozygous Familial Hypercholesterolemia Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Homozygous Familial Hypercholesterolemia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Homozygous Familial Hypercholesterolemia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Homozygous Familial Hypercholesterolemia Treatment Market Report

Report Metric Details
Report Name Homozygous Familial Hypercholesterolemia Treatment Market
CAGR 5%
Segment by Type
Segment by Application
  • Clinic
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CymaBay Therapeutics Inc, Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc, Regeneron Pharmaceuticals Inc, RegenxBio Inc, The Medicines Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Homozygous Familial Hypercholesterolemia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Homozygous Familial Hypercholesterolemia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Homozygous Familial Hypercholesterolemia Treatment Market report?

Ans: The main players in the Homozygous Familial Hypercholesterolemia Treatment Market are CymaBay Therapeutics Inc, Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc, Regeneron Pharmaceuticals Inc, RegenxBio Inc, The Medicines Company

What are the Application segmentation covered in the Homozygous Familial Hypercholesterolemia Treatment Market report?

Ans: The Applications covered in the Homozygous Familial Hypercholesterolemia Treatment Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Homozygous Familial Hypercholesterolemia Treatment Market report?

Ans: The Types covered in the Homozygous Familial Hypercholesterolemia Treatment Market report are AEM-2802, AEM-2814, Alirocumab, Evinacumab, Others

Recommended Reports

Cardiovascular Treatments

Rare Disease Therapies

Metabolic Disorder Markets

1 Homozygous Familial Hypercholesterolemia Treatment Market Overview
1.1 Product Definition
1.2 Homozygous Familial Hypercholesterolemia Treatment by Type
1.2.1 Global Homozygous Familial Hypercholesterolemia Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 AEM-2802
1.2.3 AEM-2814
1.2.4 Alirocumab
1.2.5 Evinacumab
1.2.6 Others
1.3 Homozygous Familial Hypercholesterolemia Treatment by Application
1.3.1 Global Homozygous Familial Hypercholesterolemia Treatment Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Homozygous Familial Hypercholesterolemia Treatment Market Size Estimates and Forecasts
1.4.1 Global Homozygous Familial Hypercholesterolemia Treatment Revenue 2020-2031
1.4.2 Global Homozygous Familial Hypercholesterolemia Treatment Sales 2020-2031
1.4.3 Global Homozygous Familial Hypercholesterolemia Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Homozygous Familial Hypercholesterolemia Treatment Market Competition by Manufacturers
2.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Homozygous Familial Hypercholesterolemia Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Homozygous Familial Hypercholesterolemia Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Homozygous Familial Hypercholesterolemia Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Homozygous Familial Hypercholesterolemia Treatment, Product Type & Application
2.7 Global Key Manufacturers of Homozygous Familial Hypercholesterolemia Treatment, Date of Enter into This Industry
2.8 Global Homozygous Familial Hypercholesterolemia Treatment Market Competitive Situation and Trends
2.8.1 Global Homozygous Familial Hypercholesterolemia Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Homozygous Familial Hypercholesterolemia Treatment Players Market Share by Revenue
2.8.3 Global Homozygous Familial Hypercholesterolemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Homozygous Familial Hypercholesterolemia Treatment Market Scenario by Region
3.1 Global Homozygous Familial Hypercholesterolemia Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Region: 2020-2031
3.2.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Region: 2020-2025
3.2.2 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Region: 2026-2031
3.3 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Region: 2020-2031
3.3.1 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Region: 2020-2025
3.3.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Region: 2026-2031
3.4 North America Homozygous Familial Hypercholesterolemia Treatment Market Facts & Figures by Country
3.4.1 North America Homozygous Familial Hypercholesterolemia Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2020-2031)
3.4.3 North America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Homozygous Familial Hypercholesterolemia Treatment Market Facts & Figures by Country
3.5.1 Europe Homozygous Familial Hypercholesterolemia Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2020-2031)
3.5.3 Europe Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Homozygous Familial Hypercholesterolemia Treatment Market Facts & Figures by Country
3.7.1 Latin America Homozygous Familial Hypercholesterolemia Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2020-2031)
3.7.3 Latin America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Type (2020-2031)
4.1.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Type (2020-2025)
4.1.2 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Type (2026-2031)
4.1.3 Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2020-2031)
4.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Type (2020-2031)
4.2.1 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Type (2020-2025)
4.2.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Type (2026-2031)
4.2.3 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Homozygous Familial Hypercholesterolemia Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Application (2020-2031)
5.1.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Application (2020-2025)
5.1.2 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Application (2026-2031)
5.1.3 Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2020-2031)
5.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Application (2020-2031)
5.2.1 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Application (2020-2025)
5.2.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Application (2026-2031)
5.2.3 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Homozygous Familial Hypercholesterolemia Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CymaBay Therapeutics Inc
6.1.1 CymaBay Therapeutics Inc Company Information
6.1.2 CymaBay Therapeutics Inc Description and Business Overview
6.1.3 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product Portfolio
6.1.5 CymaBay Therapeutics Inc Recent Developments/Updates
6.2 Daewoong Co Ltd
6.2.1 Daewoong Co Ltd Company Information
6.2.2 Daewoong Co Ltd Description and Business Overview
6.2.3 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Product Portfolio
6.2.5 Daewoong Co Ltd Recent Developments/Updates
6.3 Gemphire Therapeutics Inc
6.3.1 Gemphire Therapeutics Inc Company Information
6.3.2 Gemphire Therapeutics Inc Description and Business Overview
6.3.3 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product Portfolio
6.3.5 Gemphire Therapeutics Inc Recent Developments/Updates
6.4 LipimetiX Development Inc
6.4.1 LipimetiX Development Inc Company Information
6.4.2 LipimetiX Development Inc Description and Business Overview
6.4.3 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Product Portfolio
6.4.5 LipimetiX Development Inc Recent Developments/Updates
6.5 Regeneron Pharmaceuticals Inc
6.5.1 Regeneron Pharmaceuticals Inc Company Information
6.5.2 Regeneron Pharmaceuticals Inc Description and Business Overview
6.5.3 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Product Portfolio
6.5.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
6.6 RegenxBio Inc
6.6.1 RegenxBio Inc Company Information
6.6.2 RegenxBio Inc Description and Business Overview
6.6.3 RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Product Portfolio
6.6.5 RegenxBio Inc Recent Developments/Updates
6.7 The Medicines Company
6.7.1 The Medicines Company Company Information
6.7.2 The Medicines Company Description and Business Overview
6.7.3 The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Product Portfolio
6.7.5 The Medicines Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Homozygous Familial Hypercholesterolemia Treatment Industry Chain Analysis
7.2 Homozygous Familial Hypercholesterolemia Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Homozygous Familial Hypercholesterolemia Treatment Production Mode & Process Analysis
7.4 Homozygous Familial Hypercholesterolemia Treatment Sales and Marketing
7.4.1 Homozygous Familial Hypercholesterolemia Treatment Sales Channels
7.4.2 Homozygous Familial Hypercholesterolemia Treatment Distributors
7.5 Homozygous Familial Hypercholesterolemia Treatment Customer Analysis
8 Homozygous Familial Hypercholesterolemia Treatment Market Dynamics
8.1 Homozygous Familial Hypercholesterolemia Treatment Industry Trends
8.2 Homozygous Familial Hypercholesterolemia Treatment Market Drivers
8.3 Homozygous Familial Hypercholesterolemia Treatment Market Challenges
8.4 Homozygous Familial Hypercholesterolemia Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CymaBay Therapeutics Inc
Daewoong Co Ltd
Gemphire Therapeutics Inc
LipimetiX Development Inc
Regeneron Pharmaceuticals Inc
REGENXBIO
The Medicines Company
List of Tables
 Table 1. Global Homozygous Familial Hypercholesterolemia Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Homozygous Familial Hypercholesterolemia Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Homozygous Familial Hypercholesterolemia Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Homozygous Familial Hypercholesterolemia Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Homozygous Familial Hypercholesterolemia Treatment Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Homozygous Familial Hypercholesterolemia Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Homozygous Familial Hypercholesterolemia Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Homozygous Familial Hypercholesterolemia Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Homozygous Familial Hypercholesterolemia Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Homozygous Familial Hypercholesterolemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Homozygous Familial Hypercholesterolemia Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Homozygous Familial Hypercholesterolemia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Homozygous Familial Hypercholesterolemia Treatment Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Homozygous Familial Hypercholesterolemia Treatment Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Homozygous Familial Hypercholesterolemia Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Homozygous Familial Hypercholesterolemia Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Homozygous Familial Hypercholesterolemia Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Homozygous Familial Hypercholesterolemia Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Homozygous Familial Hypercholesterolemia Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) by Application (2026-2031)
 Table 70. CymaBay Therapeutics Inc Company Information
 Table 71. CymaBay Therapeutics Inc Description and Business Overview
 Table 72. CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product
 Table 74. CymaBay Therapeutics Inc Recent Developments/Updates
 Table 75. Daewoong Co Ltd Company Information
 Table 76. Daewoong Co Ltd Description and Business Overview
 Table 77. Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Product
 Table 79. Daewoong Co Ltd Recent Developments/Updates
 Table 80. Gemphire Therapeutics Inc Company Information
 Table 81. Gemphire Therapeutics Inc Description and Business Overview
 Table 82. Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product
 Table 84. Gemphire Therapeutics Inc Recent Developments/Updates
 Table 85. LipimetiX Development Inc Company Information
 Table 86. LipimetiX Development Inc Description and Business Overview
 Table 87. LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Product
 Table 89. LipimetiX Development Inc Recent Developments/Updates
 Table 90. Regeneron Pharmaceuticals Inc Company Information
 Table 91. Regeneron Pharmaceuticals Inc Description and Business Overview
 Table 92. Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Product
 Table 94. Regeneron Pharmaceuticals Inc Recent Developments/Updates
 Table 95. RegenxBio Inc Company Information
 Table 96. RegenxBio Inc Description and Business Overview
 Table 97. RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Product
 Table 99. RegenxBio Inc Recent Developments/Updates
 Table 100. The Medicines Company Company Information
 Table 101. The Medicines Company Description and Business Overview
 Table 102. The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Product
 Table 104. The Medicines Company Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Homozygous Familial Hypercholesterolemia Treatment Distributors List
 Table 108. Homozygous Familial Hypercholesterolemia Treatment Customers List
 Table 109. Homozygous Familial Hypercholesterolemia Treatment Market Trends
 Table 110. Homozygous Familial Hypercholesterolemia Treatment Market Drivers
 Table 111. Homozygous Familial Hypercholesterolemia Treatment Market Challenges
 Table 112. Homozygous Familial Hypercholesterolemia Treatment Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Homozygous Familial Hypercholesterolemia Treatment
 Figure 2. Global Homozygous Familial Hypercholesterolemia Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Homozygous Familial Hypercholesterolemia Treatment Market Share by Type: 2024 & 2031
 Figure 4. AEM-2802 Product Picture
 Figure 5. AEM-2814 Product Picture
 Figure 6. Alirocumab Product Picture
 Figure 7. Evinacumab Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Homozygous Familial Hypercholesterolemia Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Homozygous Familial Hypercholesterolemia Treatment Market Share by Application: 2024 & 2031
 Figure 11. Clinic
 Figure 12. Hospital
 Figure 13. Others
 Figure 14. Global Homozygous Familial Hypercholesterolemia Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Homozygous Familial Hypercholesterolemia Treatment Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Homozygous Familial Hypercholesterolemia Treatment Sales (2020-2031) & (K Pcs)
 Figure 17. Global Homozygous Familial Hypercholesterolemia Treatment Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Homozygous Familial Hypercholesterolemia Treatment Report Years Considered
 Figure 19. Homozygous Familial Hypercholesterolemia Treatment Sales Share by Manufacturers in 2024
 Figure 20. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Homozygous Familial Hypercholesterolemia Treatment Players: Market Share by Revenue in Homozygous Familial Hypercholesterolemia Treatment in 2024
 Figure 22. Homozygous Familial Hypercholesterolemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Homozygous Familial Hypercholesterolemia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Country (2020-2031)
 Figure 25. North America Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Country (2020-2031)
 Figure 29. Europe Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Region (2020-2031)
 Figure 37. China Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Homozygous Familial Hypercholesterolemia Treatment by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Homozygous Familial Hypercholesterolemia Treatment by Type (2020-2031)
 Figure 59. Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Homozygous Familial Hypercholesterolemia Treatment by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Homozygous Familial Hypercholesterolemia Treatment by Application (2020-2031)
 Figure 62. Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Homozygous Familial Hypercholesterolemia Treatment Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Hyperlipidemia Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperlipidemia Drugs Market Research Report 2024
Global Type I Hyperlipoproteinemia Drug Market Research Report 2025
Homozygous Familial Hypercholesterolemia Epidemiology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hypertriglyceridemia Treatment Market Research Report 2025
Drugs to Treat Hypertriglyceridemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cholesterol Lowering Drugs Market Research Report 2024
Cholesterol Reducer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Progressive Familial Intrahepatic Cholestasis Cholestyramine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genetic Disease Diagnosis Market Research Report 2024
Lipid lowering Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hypertensive Heart Disease Drug Market Research Report 2025
Clinical Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Cholesterol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyperbilirubinemia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Prenatal Genetic Testing Market Research Report 2025
Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Congenital hyperinsulinism HI Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Waldenstrom s Macroglobulinemia Treatment Market Research Report 2024
Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions